Bioter SA (Greece) Analysis

BIOT Stock  EUR 0.29  0.03  9.38%   
Bioter SA is overvalued with Real Value of 0.25 and Hype Value of 0.29. The main objective of Bioter SA stock analysis is to determine its intrinsic value, which is an estimate of what Bioter SA is worth, separate from its market price. There are two main types of Bioter SA's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Bioter SA's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Bioter SA's stock to identify patterns and trends that may indicate its future price movements.
The Bioter SA stock is traded in Greece on Athens Exchange, with the market opening at 10:15:00 and closing at 17:20:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Greece. Bioter SA is usually not traded on Easter Monday, International Workers ' Day, Pentecost_, Assumption of Mary, OhiDay, Christmas Eve, Christmas Day, Boxing Day _, New Year 's Day, Epiphany, CleanMonday, IndependenceDay, Good Friday. Bioter Stock trading window is adjusted to Europe/Athens timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioter SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Bioter Stock Analysis Notes

About 42.0% of the company shares are held by company insiders. The company last dividend was issued on the 18th of August 2006. Bioter SA had 0:1 split on the 9th of August 2010. Bioter S.A. operates as a construction company in Greece and internationally. The company was founded in 1962 and is based in Athens, Greece. BIOTER S is traded on Athens Stock Exchange in Greece. For more info on Bioter SA please contact Dimitrios Bersos at 30 210 72 48 762 or go to https://www.bioter.gr.

Bioter SA Investment Alerts

Bioter SA has some characteristics of a very speculative penny stock
Bioter SA had very high historical volatility over the last 90 days
Bioter SA has high likelihood to experience some financial distress in the next 2 years
Bioter SA has accumulated 143.2 M in total debt. Bioter SA has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioter SA until it has trouble settling it off, either with new capital or with free cash flow. So, Bioter SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioter SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioter to invest in growth at high rates of return. When we think about Bioter SA's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 241 K. Net Loss for the year was (8.81 M) with loss before overhead, payroll, taxes, and interest of (935 K).
Bioter SA has accumulated about 255 K in cash with (6.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 42.0% of the company shares are held by company insiders

Bioter Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioter SA's market, we take the total number of its shares issued and multiply it by Bioter SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 26th of November, Bioter SA shows the Risk Adjusted Performance of 0.0756, mean deviation of 2.24, and Downside Deviation of 10.23. Bioter SA technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Bioter SA Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bioter SA middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bioter SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Bioter SA Outstanding Bonds

Bioter SA issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bioter SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bioter bonds can be classified according to their maturity, which is the date when Bioter SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Bioter SA Predictive Daily Indicators

Bioter SA intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bioter SA stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Bioter SA Forecast Models

Bioter SA's time-series forecasting models are one of many Bioter SA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bioter SA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Bioter Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bioter SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bioter shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bioter SA. By using and applying Bioter Stock analysis, traders can create a robust methodology for identifying Bioter entry and exit points for their positions.
Bioter S.A. operates as a construction company in Greece and internationally. The company was founded in 1962 and is based in Athens, Greece. BIOTER S is traded on Athens Stock Exchange in Greece.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Bioter SA to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Financial Widgets Now

   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module

Additional Tools for Bioter Stock Analysis

When running Bioter SA's price analysis, check to measure Bioter SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioter SA is operating at the current time. Most of Bioter SA's value examination focuses on studying past and present price action to predict the probability of Bioter SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioter SA's price. Additionally, you may evaluate how the addition of Bioter SA to your portfolios can decrease your overall portfolio volatility.